Glycine-extended gastrin induces matrix metalloproteinase-1- and -3-mediated invasion of human colon cancer cells through type I collagen gel and matrigel

International Journal of Cancer

Volumn 111, Issue 1, 2004, Pages 23-31

  Baba, Miyako ^a   Itoh, Kazuyuki ^a   Tatsuta, Masaharu ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Colon cancer cells; Glycine extended gastrin; Invasion and metastasis; Matrix metalloproteinase 1, 3; Type I collagen

Indexed keywords

1 [2,3 DIHYDRO 1 (2' METHYLPHENACYL) 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL] 3 (3 METHYLPHENYL)UREA; ARF PROTEIN; BENZOTRIPT; CD147 ANTIGEN; CGS 27023A; COAT PROTEIN; COLLAGEN TYPE 1; COMPLEMENTARY DNA; GASTRIN; GASTRIN RECEPTOR; GELATINASE A; GELATINASE B; GLYCINE; GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN G; INTERSTITIAL COLLAGENASE; MATRIGEL; PROGLUMIDE; PROTEIN GGA 2; SMALL INTERFERING RNA; STROMELYSIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CANCER CELL CULTURE; CANCER INVASION; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; CYTOPLASM VESICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; GENETIC TRANSFECTION; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BIOCOMPATIBLE MATERIALS; COLLAGEN; COLLAGEN TYPE I; COLONIC NEOPLASMS; DNA, COMPLEMENTARY; DRUG COMBINATIONS; GASTRINS; GELS; HUMANS; LAMININ; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; NEOPLASM INVASIVENESS; PROTEOGLYCANS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 3042736017     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20207     Document Type: Article

References (46)

1. Wang TC, Dockray GJ. Lessons from genetically engineered animal models. I. Physiological studies with gastrin in transgenic mice. Am J Physiol 1999;227:G6-G11.
2. Van Solinge WW, Nielsen FC, Friis-Hansen L, Falkmer UG, Rehfeld JF. Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology 1993;104:1099-107.
3. Dockray GJ. Topical review: gastrin and gastric epithelial physiology. J Physiol 1999;518:315-24.
4. Dockray GJ, Varro A, Dimaline R, Wang T. The gastrins: their production and biological activities. Ann Rev Physiol 2001;63:119-39.
5. Ji TH, Grossmann M, Ji I. G protein-coupled receptors. I. Diversity of receptor-ligand interactions. J Biol Chem 1998;273:17299-302.
6. Zavros Y, Paterson A, Lambert J, Shulkes A. Expression of progastrin-derived peptides and somatostatin in fundus and antrum of non-ulcer dyspepsia subjects with and without Helicobactor pylori infection. Dig Dis Sci 2000;45:2058-64.
7. Koh TJ, Dockray GJ, Varro A, Cahill RJ, Dangler CA, Fox JG, Wang TC. Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation. J Clin Invest 1999;103:1119-26.
8. Seva C, Dickinson CJ, Yamada, T. Growth-promoting effects of glycine-extended progastrin. Science 1994;265:410-2.
9. Stepan VM, Sawada M, Todisco A, Dickinson CJ. Glycine-extended gastrin exerts growth-promoting effects on human colon cancer cells. Mol Med 1999;5:147-59.
10. 17 stimulates both proliferation and formation of aberrant crypt foci in rat colonic mucosa. Int J Cancer 2001;94:307-13.
11. Hollande F, Choquet A, Blanc EM, Lee DJ, Bali J-P, Baldwin GS. Involvement of phosphatidylinositol 3-kinase and mitogen-activated protein kinases in glycine-extended gastrin-induced dissociation and migration of gastric epithelial cells. J Biol Chem 2001;276:40402-10.
12. Kermorgant S, Lehy T. Glycine-extended gastrin promotes the invasiveness of human colon cancer cells. Biochem Biophys Res Commun 2001;285:136-41.
13. Poste G, Fidler IJ. The pathogenesis of cancer metastasis. Nature 1980;283:139-46.
14. Nagase H. In zinc metalloproteinases and in health and disease. In: Hooper NM, ed. London: Taylor & Francis, 1996. 153-204.
15. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999;274:21491-4.
16. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 2000;14:163-76.
17. 165. J Biol Chem 2002;277:36288-95.
18. Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM, Mareel M. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2000;114:111-18.
19. Suzuki K, Enghild JJ, Morodomi T, Salvesen G, Nagase H. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase-3 (stromelysin). Biochemistry 1990;29:10261-70.
20. Hahn-Dantona E, Ramos-DeSimone N, Sipley J, Nagase H, French DL, Quigley JP. Activation of proMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model: regulation by tissue inhibitors of metalloproteinases. Ann NY Acad Sci 1999;878:372-87.
21. Brinckerhoff CE, Rutter JL, Benbow U. Interstitial collagenases as markers of tumor progression. Clin Cancer Res 2000;6:4823-30.
22. Shiozawa J, Ito M, Nakayama T, Nakashima M, Kohno S, Sekine I. Expression of matrix metalloproteinase-1 in human colorectal carcinoma. Mod Pathol 2000;13:925-33.
23. Chang RSL, Lotti VJ, Monaghan RL, Birnbaum J, Stapley EO, Goetz MA, Albers-Schonberg G, Patchett AA, Liesch JM, Hensens OD, Springer JP. A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus. Science 1985;230:177-9.
24. Hoosein NM, Kiener PA, Curry RC, Rovati LC, McGilbra DK, Brattain MG. Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines. Cancer Res 1998;48:7179-83.
25. Murayama T, Matsumoto Y, Iwata N, Ito M, Taniguchi T, Chihara K, Matsui T. Antiproliferative effect of a novel cholecystokinin-B/gastrin receptor antagonist, YM022. Jpn J Cancer Res 1996;87:743-50.
26. Koshikawa N, Yasumitu H, Umeda M, Miyazaki K. Multiple secretion of matrix serine proteases by human gastric carcinoma cell lines. Cancer Res 1992;52:5046-53.
27. Qian L-W, Mizumoto K, Urashima T, Nagai E, Maehara N, Sato N, Nakajima M, Tanaka M. Experimental therapeutics, preclinical pharmacology. Radiation-induced increase in invasion potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. Clin Cancer Res 2002;8:1223-7.
28. Kanekura T, Chen X, Kanzaki T. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer 2002;99:520-8.
29. Hirst J, Lui WW, Bright NA, Totty N, Seaman MN, Robinson MS. A family of proteins with γ-adaptin and VHS domains that facilitate trafficking between the trans-Golgi network and the vacuole/lysosome. J Cell Biol 2000;149:67-80.
30. Takahashi S, Nakagawa T, Kasai K, Banno T, Duguay SJ, Van de Ven WJM, Murakami K, Nakayama K. A second mutant allele of furin in the processing-incompetent cell line, LoVo. J Biol Chem 1995;270:26565-9.
31. Birkedal-Hansen H, Moor WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix metalloproteinase: a review. Crit Rev Oral Biol Med 1993;4:197-250.
32. Dell'Angelica EC, Puertollano R, Mullins C, Aguilar RC, Vargas JD, Hartnell LM, Bonifacino JS. GGAs: a family of ADP ribosylation factor-binding proteins related to adaptors and associated with the Golgi complex. J Cell Biol 2000;149:81-93.
33. Guo H, Li R, Zucker S, Toole BP. EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface. Cancer Res 2000;60:888-91.
34. D'Angelo M, Billings PC, Pacifici M, Leboy PS, Kirsch T. Authentic matrix vesicles contain active metalloproteinases (MMP). J Biol Chem 2001;276:11347-53.
35. Hollande F, Lee DJ, Choquet A, Roche S, Baldwin GS. Adherens junctions and tight junctions are regulated via different pathways by progastrin in epithelial cells. J Cell Sci 2003;116:1187-97.
36. Nikkola J, Vihinen P, Vlaykova T, Hahka-Kemppinen M, Kahari V-M, Pyrhonen S. High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma. Int J Cancer 2002;97:432-8.
37. Gutman A, Wasylyk B. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J 1990;9:2241-6.
38. Wasylyk C, Gutman A, Nicholson R, Wasylyk B. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J 1991;10:1127-34.
39. Reunanen N, Li S-P, Ahonen M, Foschi M, Han J, Kahari V-M. Activation of p38α MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization. J Biol Chem 2002;277:32360-8.
40. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994;370:61-5.
41. Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M. Activation of a recombinant membrane type 1-matrix metalloproteinase (MTI-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 1996;393:101-4.
42. Wroblewski LE, Pritchard DM, Carter S, Varro A. Gastrin-stimulated gastric epithelial cell invasion: the role and mechanism of increased matrix metalloproteinase 9 expression. Biochem J 2002;365:873-9.
43. Siddheshwar RK, Gray JC, Kelly SB. Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma. Gut 2001;48:47-52.
44. Nemeth J, Taylor B, Pauwels S, Varro A, Dockray GJ. Identification of progastrin derived peptides in colorectal carcinoma extracts. Gut 1993;34:90-5.
45. Yang CH, Ford J, Karelina Y, Shulkers A, Xiao SD, Baldwin GS. Identification of a 70-kDa gastrin-binding protein on DLD-1 human colorectal carcinoma cells. Int J Biochem Cell Biol 2001;33:1071-9.
46. Karelina Y, Baldwin GS. Colon inflammation, cell growth and carcinoma. Binding sites for progastrin-derived peptides in colonic cripts. J Gastroenterol Hepatol 2001;16:169-75.